Special notice
Justification & Approval for Sole Source: Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs)
75F40124Q122639J-A
Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
March 25, 2024 at 11:00 AM EDT
Closed 907 days ago. Posted March 19, 2024. Scheduled to archive April 9, 2024.
Description
As published on SAM.gov.
See J&A for Sole Source procurement for Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs). See also associated Intent to Sole Source and RFQ under notice #: 75F40124Q122639
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
March 19, 2024
Special notice
Due March 25, 2024 at 11:00 AM EDT. SAM.gov, notice d94e793dfb1a4759b1dba1362f42e097
Points of contact
- Suzanne Martellasuzanne.martella@fda.hhs.gov8705437540
Also open from this buyer
- Animal BloodCombined synopsis and solicitationSmall businessNAICS 325414Silver Spring, MDCDRH2026134634Closes todaySep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes todaySep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 3 daysSep 21
- Fourier Transform Infrared Spectrophotometer (FTIR)Combined synopsis and solicitationNAICS 334516San Juan, PR75F40126Q00406Closes in 4 daysSep 22
- 2D High-Density Multi-Electrode Array Electrophysiology PlatformCombined synopsis and solicitationNAICS 334516RFQ_CBER-2026-135968Closes in 5 daysSep 23